At GSK, we are committed to searching for new treatments for many of the diseases that affect millions of people in some of the world’s least well off nations. We have a heritage and expertise in researching and developing new medicines and vaccines, and we are directing our scientific resources into this important area.
We have a specialist research centre in Spain, which was dedicated when it opened in 2001 to carrying out research into global health priorities like malaria and TB.
Since the centre opened,
we have worked closely with alliance partners on our projects. We announced in February 2009 our intention to seek out new alliance partners and new collaborations with the aim of opening up this centre.
By opening the centre to more alliances and collaborations, we can provide a critical mass of knowledge and drive for the discovery and development of desperately-needed new medicines, it can become a truly world-leading facility that will stimulate research and collaboration in this critical area.
The fight against these diseases is a global challenge in which many stakeholders have an important role to play.
Learn more about the role that GSK has to play and about the steps we are taking to defeat diseases like malaria, TB, leishmaniasis and trypanosomiasis infections.
